Recombinant Human EAAT4 Protein，His

The study of EAAT4 (Excitatory Amino Acid Transporter 4) recombinant proteins has garnered significant interest due to their crucial role in maintaining excitatory neurotransmitter homeostasis in the central nervous system. EAATs are responsible for the reuptake of glutamate, the primary excitatory neurotransmitter, thereby preventing excessive glutamate accumulation, which can lead to excitotoxicity and neurodegeneration. EAAT4 is predominantly expressed in the cerebellum and was initially characterized for its unique transport properties and regulatory mechanisms. Advances in molecular biology techniques have enabled the production of recombinant EAAT4 proteins, facilitating in-depth studies of their structure, function, and interaction with various ligands. This research is pivotal for understanding the molecular basis of synaptic transmission and its implications in neurological disorders such as epilepsy, autism spectrum disorders, and neurodegenerative diseases. Furthermore, the elucidation of EAAT4's binding sites and transport mechanisms could contribute to the development of targeted therapeutics aimed at modulating glutamate levels, thereby offering potential strategies for treating synaptic dysfunction and associated pathologies. Overall, the exploration of EAAT4 recombinant proteins not only enhances our fundamental understanding of glutamate transport but also opens avenues for novel clinical interventions in the realm of neurobiology.